Free Trial
NASDAQ:BBLGW

Bone Biologics (BBLGW) Stock Price, News & Analysis

Bone Biologics logo
$20.20 -0.60 (-2.88%)
As of 03/25/2025

About Bone Biologics Stock (NASDAQ:BBLGW)

Key Stats

Today's Range
$20.20
$21.64
50-Day Range
$20.20
$95.00
52-Week Range
$3.00
$95.04
Volume
411 shs
Average Volume
2,218 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Remove Ads
Receive BBLGW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

BBLGW Stock News Headlines

BBLG in Good Shape as Testing Continues
Tellgen Corporation (300642.SZ)
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....
BBLG: Controls Costs and Advances Trials
Bone Biologics Corp Warrants (BBLGW)
See More Headlines

BBLGW Stock Analysis - Frequently Asked Questions

Bone Biologics' stock was trading at $40.00 at the beginning of 2025. Since then, BBLGW stock has decreased by 49.5% and is now trading at $20.20.
View the best growth stocks for 2025 here
.

Bone Biologics shares reverse split before market open on Wednesday, June 7th 2023. The 1-30 reverse split was announced on Wednesday, June 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Top institutional investors of Bone Biologics include Citadel Advisors LLC.

Shares of BBLGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBLGW
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:BBLGW) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners